Does lavender actually reduce anxiety?

Standardised oral lavender oil at 80 mg daily reduced anxiety scores in multiple randomised placebo-controlled trials. Aromatherapy and tea have far weaker evidence.

How long does it take to work?

Separation from placebo typically appeared by week two, with fuller effects by week six. It is not a rescue remedy.

Is it sedating or habit-forming?

No. It does not act at the benzodiazepine receptor site, and trials found no sedation, tolerance or withdrawal.

Can I take it with an antidepressant?

It has been used alongside SSRIs in practice without clear interaction, but tell your prescriber before adding it.

Can I just swallow lavender essential oil?

No. Aromatherapy oil is not made for ingestion and can be toxic. Use only capsules formulated and labelled for oral use.

Condition

Effectiveness 4/5

Lavender for Anxiety

Oral lavender oil at 80 mg/day is one of the few botanicals with randomised evidence in generalised anxiety comparable to low-dose lorazepam and paroxetine — without sedation, tolerance or withdrawal.

Overview

Lavender is unusual among botanicals for anxiety in having a standardised oral preparation with a real trial programme behind it. Silexan, an oral lavender oil capsule, has been tested in multiple randomised placebo-controlled trials in generalised anxiety disorder, subthreshold anxiety and mixed anxiety presentations, with meta-analyses reporting clinically meaningful reductions in Hamilton Anxiety Scale scores. Some trials compared it against active comparators including lorazepam and paroxetine and found comparable effect sizes without sedation or dependence — a genuinely notable result. The main reservations are that a large share of the evidence comes from studies supported by the manufacturer, and that the findings apply to that specific preparation rather than to lavender tea, aromatherapy or generic oil capsules.

Verdict

Likely effective

Multiple randomised placebo-controlled trials of standardised oral lavender oil (Silexan) at 80 mg daily show meaningful anxiety reduction within 2-6 weeks, without sedation or dependence. Manufacturer involvement is common and findings are preparation-specific.

How It Works

Linalool and linalyl acetate are the two constituents that carry the effect. The best-supported mechanism is inhibition of voltage-gated calcium channels in neurons, particularly N-type and P/Q-type channels, which reduces presynaptic neurotransmitter release and dampens the excitability of circuits involved in anxiety — a mechanism shared with pregabalin, though weaker. What lavender does not do is act at the benzodiazepine site of the GABA-A receptor, which is why trials find anxiety reduction without sedation, tolerance or withdrawal. Additional evidence points to serotonin 1A receptor modulation and, from imaging work, reduced amygdala reactivity to emotional stimuli. Absorption of the oral preparation is rapid, with plasma peaks within an hour, but clinical effects build over weeks.

Pathways involved

Voltage-gated calcium channel inhibition

Reduced presynaptic neurotransmitter release

Serotonin 1A receptor modulation

Reduced amygdala reactivity

No benzodiazepine-site GABA-A activity

Linalool and linalyl acetate as actives

Dosing & Protocol

Scenario	Dose	Form	Timing
Standardised oral trial dose	80 mg once daily	Silexan-type standardised lavender oil capsule	Morning or evening with water
Higher dose used in some trials	160 mg once daily	Standardised lavender oil capsule	Once daily
Aromatherapy	2-4 drops in a diffuser	Lavender essential oil	Evening; much weaker evidence
Tea	1-2 g dried flowers infused	Dried lavender	Evening; traditional use, minimal trial data

1
Use the standardised oral preparation· Before starting
The trial evidence is for a specific standardised lavender oil capsule. Culinary oil, tea and diffusers are not equivalent and should not be swallowed.
2
Take 80 mg once daily· Ongoing
Swallow whole with water. Some people prefer the evening because it also improves sleep quality disturbed by anxiety.
3
Allow two to six weeks· Weeks 1-6
Trials typically showed separation from placebo by week two, with fuller effects by week six. It is not an as-needed anxiolytic.
4
Track with a scale, not a feeling· Weekly
A brief validated measure such as GAD-7, recorded weekly, is far more reliable than recalling how the last fortnight felt.
5
Keep it in its place· Ongoing
For moderate to severe anxiety disorders, lavender is an adjunct. It should not delay access to psychological therapy or prescribed treatment.

Never swallow undiluted essential oil

Lavender essential oil sold for aromatherapy is not formulated for ingestion and can be toxic if swallowed. Only preparations manufactured and labelled for oral use, at the studied dose, should be taken by mouth.

Evidence

The linked evidence base is unusually coherent for a botanical. A 2023 meta-analysis of randomised placebo-controlled trials in patients with anxiety disorders found consistent reductions in anxiety scores with Silexan, and a separate 2019 meta-analysis reached the same conclusion in subthreshold anxiety. A randomised double-blind trial in generalised anxiety disorder examined efficacy and tolerability directly, and a 2019 study assessed efficacy and safety in patients with anxiety disorders. The shared limitation across these is provenance: much of the programme was conducted or supported by the manufacturer of the preparation, and independent replication remains thin. Effect sizes are nonetheless consistent across trials and populations. Four studies are linked to this pairing and listed below.

Two meta-analyses of randomised placebo-controlled Silexan trials (anxiety disorders and subthreshold anxiety), a randomised double-blind trial in generalised anxiety disorder, and an efficacy and safety study in anxiety disorder patients.

Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials

Score: 8/10

2023

meta_analysis

n=1573

Dold M, Bartova L, Volz HP

Silexan was significantly superior to placebo in reducing HAMA total scores in patients with anxiety disorders.

View source

Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials

Score: 7/10

2019

meta_analysis

n=1173

Moller HJ, Volz HP, Dienel A

Silexan improved anxiety, sleep quality and health-related quality of life in patients with subthreshold anxiety.

View source

Silexan in generalized anxiety disorder: investigation of the efficacy and tolerability in a randomized, double-blind, placebo-controlled trial with paroxetine as active control

Score: 8/10

2014

rct

n=539

Kasper S, Gastpar M, Muller WE

Silexan 160 mg/day significantly reduced HAMA total score versus placebo in generalized anxiety disorder.

View source

Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders: A network meta-analysis

Score: 7/10

2019

meta_analysis

n=1200

Yap WS, Dolzhenko AV, Jalal Z

Silexan 160 mg showed anxiolytic effects comparable to paroxetine and lorazepam with a favourable adverse event profile.

View source

Best available evidence: Meta-analyses of randomised placebo-controlled Silexan trials
Typical effect: Clinically meaningful reduction in Hamilton Anxiety Scale scores
Studied dose: 80 mg daily standardised oral lavender oil
Time to effect: 2-6 weeks
Main limitation: Manufacturer involvement across much of the trial programme

Safety

No sedation, tolerance or withdrawal

Unlike benzodiazepines, lavender oil does not act at the GABA-A benzodiazepine site. Trials report no sedation, no dependence and no withdrawal on stopping — which is the main practical argument for trying it in mild to moderate anxiety.

Points to watch

Lavender-scented burping (the most common complaint)

Mild nausea or reflux

Skin sensitisation with topical use

Insufficient data in pregnancy and breastfeeding

Debated and unconfirmed reports of hormonal effects in prepubertal boys

Interactions & Conflicts

Interacts with	Severity	Mechanism	Action
Benzodiazepines and Z-drugs	low	Possible additive central effects, though lavender is non-sedating alone	Monitor for excess drowsiness
SSRIs and SNRIs	low	Commonly used alongside in trials; no clear pharmacokinetic conflict	Reasonable to combine; tell your prescriber
Anticonvulsants and pregabalin	low	Shared calcium channel mechanism may be additive	Discuss with a clinician if on treatment
Alcohol	low	Additive central depressant effect	Moderate intake, especially when starting
General anaesthesia	low	Central depressant effects around surgery	Mention it during pre-operative assessment

References

Frequently Asked Questions

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.